tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Akari Therapeutics PLC

AKTX
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
9.160USD
-0.715-7.24%
์ข…๊ฐ€ย 09-18 16:00๏ผˆET๏ผ‰
651.85M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Akari Therapeutics PLC

9.160
-0.715-7.24%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

AKTX ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Akari Therapeutics PLC์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
651.85M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-0.60
์ฃผ๋‹น์ˆœ์ด์ต
-15.44
์ˆ˜์ต
--
์ˆœ์ด์ต
-19.79M
ROE
-155.28%
ROA
-66.11%

Akari Therapeutics PLC ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 13, 2026
EPS / ์˜ˆ์ƒ
-2.40/-1.28
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
์žฌ๋ฌด ์ง€ํ‘œ
EPS
0.00%-2.40
-7900.00%-384.00
40.00%-0.12
16.67%-0.20
92.50%-0.06
85.37%-0.12
---0.20
---0.24
---0.80
---0.82
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
์ˆœ์ด์ต
-153.67%-4.81M
-290.15%-14.46M
-40.46%-5.30M
-121.07%-6.40M
74.93%-1.90M
33.44%-3.71M
---3.77M
---2.90M
---7.56M
---5.57M
----
----
----
----
----
-30.68%-5.68M
11.34%-5.18M
15.15%-5.79M
-258.89%-1.45M
41.58%-4.35M
-72.48%-5.84M
10.46%-6.82M
135.61%913.45K
-80.71%-7.44M
-32.99%-3.39M
๋ถ€์ฑ„๋น„์œจ
-40.95%1.79%
-40.37%2.16%
-75.58%1.57%
-87.24%4.67%
-84.58%3.04%
--3.62%
--6.45%
--36.58%
--19.70%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์˜์—… ์ด์ต
-47.55%-4.60M
-2.92%-3.63M
24.87%-3.23M
-20.09%-2.22M
43.85%-3.12M
41.14%-3.52M
---4.29M
---1.85M
---5.55M
---5.99M
----
----
----
----
----
-34.32%-5.82M
5.49%-5.24M
14.84%-5.87M
-492.75%-1.46M
26.75%-4.33M
-12.62%-5.55M
13.35%-6.90M
95.90%-246.88K
1.99%-5.91M
-1.36%-4.93M
์ˆœ์ด์ต
-153.67%-4.81M
-290.15%-14.46M
-40.46%-5.30M
-121.07%-6.40M
74.93%-1.90M
33.44%-3.71M
---3.77M
---2.90M
---7.56M
---5.57M
----
----
----
----
----
-30.68%-5.68M
11.34%-5.18M
15.15%-5.79M
-258.89%-1.45M
41.58%-4.35M
-72.48%-5.84M
10.46%-6.82M
135.61%913.45K
-80.71%-7.44M
-32.99%-3.39M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
152.17%8.32M
7.17%3.59M
85.03%5.46M
7.75%2.95M
-34.97%3.30M
20.82%3.35M
-32.00%2.95M
--2.73M
-36.53%5.08M
--2.77M
-68.58%4.34M
----
-29.55%8.00M
----
18.84%13.81M
136.31%11.35M
148.72%19.43M
-20.25%11.63M
7.52%14.69M
-66.70%4.80M
-21.39%7.81M
126.20%14.58M
----
----
----
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-18.69%13.94M
-35.83%13.41M
-37.97%12.35M
65.13%15.57M
95.22%17.14M
230.55%20.91M
334.34%19.91M
--9.43M
67.81%8.78M
--6.33M
-61.93%4.58M
----
71.79%5.23M
----
97.60%12.04M
-6.06%3.05M
41.52%5.52M
16.72%6.09M
-62.02%3.36M
-70.83%3.24M
-52.13%3.90M
-19.34%5.22M
----
----
----
์ด ์ž์‚ฐ
-24.13%38.62M
-33.50%33.89M
-5.28%47.89M
1559.69%45.38M
902.97%50.91M
1738.35%50.96M
1061.01%50.56M
--2.73M
-36.65%5.08M
--2.77M
-68.51%4.36M
----
-29.53%8.01M
----
18.75%13.83M
135.45%11.37M
148.15%19.45M
-20.25%11.65M
7.48%14.72M
-66.58%4.83M
-21.36%7.84M
125.39%14.60M
----
----
----
๋ถ€์ฑ„ ์ด๊ณ„
-20.85%20.03M
-33.22%19.51M
-30.95%19.56M
140.66%22.69M
188.26%25.31M
361.87%29.21M
518.08%28.33M
--9.43M
67.81%8.78M
--6.33M
-61.93%4.58M
----
71.79%5.23M
----
97.60%12.04M
-6.06%3.05M
41.52%5.52M
16.72%6.09M
-62.02%3.36M
-70.83%3.24M
-52.13%3.90M
-19.34%5.22M
----
----
----
์ž๋ณธ ์ด๊ณ„
-27.38%18.59M
-33.87%14.38M
27.44%28.33M
438.92%22.69M
791.47%25.61M
712.05%21.75M
9806.99%22.23M
---6.69M
-233.13%-3.70M
---3.55M
-112.79%-229.00K
----
-66.59%2.78M
----
-67.76%1.79M
424.30%8.33M
253.87%13.93M
-40.81%5.55M
133.88%11.36M
-52.44%1.59M
116.83%3.94M
123410.38%9.38M
----
----
----
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
4.51%-3.11M
-15.72%-2.49M
-43.17%-3.04M
-42.35%-2.12M
33.47%-3.26M
46.83%-2.15M
---2.12M
---1.49M
---4.89M
---4.04M
----
----
----
----
----
-76.21%-8.57M
31.93%-5.05M
-18.21%-5.00M
-121.36%-1.56M
-13.86%-4.87M
4.15%-7.42M
-22.19%-4.23M
85.66%-704.17K
10.46%-4.27M
-3480.59%-7.74M
์ˆœํˆฌ์ž
----
----
----
----
----
----
--382.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
์ˆœ์žฌ๋ฌดํ™œ๋™
137.65%8.04M
-97.52%53.00K
167.41%5.76M
528.22%1.90M
-56.45%3.38M
40.89%2.13M
--2.15M
---443.00K
--7.76M
--1.51M
----
----
----
----
----
-100.00%0.00
--12.37M
-81.37%1.12M
--11.18M
-78.34%1.99M
-100.00%0.00
115.86%5.99M
-100.00%0.00
599.31%9.20M
6162.08%9.88M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Akari Therapeutics PLC์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Akari Therapeutics PLC์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 5.46M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 85.03์ž…๋‹ˆ๋‹ค.

Akari Therapeutics PLC์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Akari Therapeutics PLC์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Akari Therapeutics PLC์˜ ์ด์ž์‚ฐ์€ 47.89M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -5.28์ž…๋‹ˆ๋‹ค.

Akari Therapeutics PLC์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Akari Therapeutics PLC์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Akari Therapeutics PLC์˜ ์ด๋ถ€์ฑ„๋Š” 19.56M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -30.95์ž…๋‹ˆ๋‹ค.

Akari Therapeutics PLC์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Akari Therapeutics PLC์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Akari Therapeutics PLC์˜ ์ด์ž๋ณธ์€ 28.33M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 27.44์ž…๋‹ˆ๋‹ค.

Akari Therapeutics PLC์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Akari Therapeutics PLC์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Akari Therapeutics PLC์˜ ์ˆœ์˜์—…์†Œ๋“์€ -17.27M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 3.65์ž…๋‹ˆ๋‹ค.

Akari Therapeutics PLC์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Akari Therapeutics PLC์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Akari Therapeutics PLC์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 13.17M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 19.87์ž…๋‹ˆ๋‹ค.

Akari Therapeutics PLC์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Akari Therapeutics PLC์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -20.80์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 99.22์ž…๋‹ˆ๋‹ค.

Akari Therapeutics PLC์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Akari Therapeutics PLC์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -17.30M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 12.60์ž…๋‹ˆ๋‹ค.

Akari Therapeutics PLC์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Akari Therapeutics PLC์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 1.57์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -75.58์ž…๋‹ˆ๋‹ค.

Akari Therapeutics PLC์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Akari Therapeutics PLC์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -68.43์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 61.97์ž…๋‹ˆ๋‹ค.

Akari Therapeutics PLC์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Akari Therapeutics PLC์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -35.14์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 51.25์ž…๋‹ˆ๋‹ค.

Akari Therapeutics PLC์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Akari Therapeutics PLC์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -17.27M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 3.65์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ